Serum a-lactalbumin Levels as a Breast Cancer Marker
Author Information
Author(s): E.T. Thean, B.H. Toh
Primary Institution: Department of Pathology and Immunology, Monash Medical School
Hypothesis
Can serum levels of a-lactalbumin serve as a reliable marker for breast cancer?
Conclusion
The study suggests that elevated serum levels of a-lactalbumin may be useful for monitoring breast cancer.
Supporting Evidence
- 87% of pregnant women in the study had elevated a-lactalbumin levels.
- 64% of breast cancer patients showed elevated levels of a-lactalbumin.
- 70% of patients with gynaecological cancers had elevated a-lactalbumin levels.
- Patients with stage IV breast cancer had the highest levels of a-lactalbumin.
Takeaway
This study found that a special protein called a-lactalbumin is higher in women with breast cancer, which could help doctors check for the disease.
Methodology
Serum levels of a-lactalbumin were measured using a monoclonal antibody in a radioimmunoassay.
Potential Biases
The study was performed blind to prevent bias in interpreting results.
Limitations
The assay may not be suitable for early breast cancer detection and results may vary due to protein stability and heterogeneity.
Participant Demographics
Included women in the third trimester of pregnancy, patients with breast cancer, and healthy blood donors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website